Cancer Stem Cells-The Insight into Non-Coding RNAs

Cells. 2022 Nov 21;11(22):3699. doi: 10.3390/cells11223699.

Abstract

Since their initial identification three decades ago, there has been extensive research regarding cancer stem cells (CSCs). It is important to consider the biology of cancer stem cells with a particular focus on their phenotypic and metabolic plasticity, the most important signaling pathways, and non-coding RNAs (ncRNAs) regulating these cellular entities. Furthermore, the current status of therapeutic approaches against CSCs is an important consideration regarding employing the technology to improve human health. Cancer stem cells have claimed to be one of the most important group of cells for the development of several common cancers as they dictate features, such as resistance to radio- and chemotherapy, metastasis, and secondary tumor formation. Therapies which could target these cells may develop into an effective strategy for tumor eradication and a hope for patients for whom this disease remains uncurable.

Keywords: EMT; anti-cancer therapies; cancer stem cells; non-coding RNAs; phenotypic and metabolic plasticity.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Humans
  • Neoplasms* / metabolism
  • Neoplastic Stem Cells* / pathology
  • Signal Transduction

Grants and funding

This research was funded by [USDA Animal Health NC], grant number [07082].